BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 17904549)

  • 1. Different expression of protein kinase A (PKA) regulatory subunits in cortisol-secreting adrenocortical tumors: relationship with cell proliferation.
    Mantovani G; Lania AG; Bondioni S; Peverelli E; Pedroni C; Ferrero S; Pellegrini C; Vicentini L; Arnaldi G; Bosari S; Beck-Peccoz P; Spada A
    Exp Cell Res; 2008 Jan; 314(1):123-30. PubMed ID: 17904549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a clinically homogenous subgroup of benign cortisol-secreting adrenocortical tumors characterized by alterations of the protein kinase A (PKA) subunits and high PKA activity.
    Vincent-Dejean C; Cazabat L; Groussin L; Perlemoine K; Fumey G; Tissier F; Bertagna X; Bertherat J
    Eur J Endocrinol; 2008 Jun; 158(6):829-39. PubMed ID: 18505904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PKA catalytic subunit mutations in adrenocortical Cushing's adenoma impair association with the regulatory subunit.
    Calebiro D; Hannawacker A; Lyga S; Bathon K; Zabel U; Ronchi C; Beuschlein F; Reincke M; Lorenz K; Allolio B; Kisker C; Fassnacht M; Lohse MJ
    Nat Commun; 2014 Dec; 5():5680. PubMed ID: 25477193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 8Cl-cAMP modifies the balance between PKAR1 and PKAR2 and modulates the cell cycle, growth and apoptosis in human adrenocortical H295R cells.
    Bouizar Z; Ragazzon B; Viou L; Hortane M; Bertherat J; Rizk-Rabin M
    J Mol Endocrinol; 2010 Jun; 44(6):331-47. PubMed ID: 20237143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferation of transformed somatotroph cells related to low or absent expression of protein kinase a regulatory subunit 1A protein.
    Lania AG; Mantovani G; Ferrero S; Pellegrini C; Bondioni S; Peverelli E; Braidotti P; Locatelli M; Zavanone ML; Ferrante E; Bosari S; Beck-Peccoz P; Spada A
    Cancer Res; 2004 Dec; 64(24):9193-8. PubMed ID: 15604292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity.
    Bertherat J; Groussin L; Sandrini F; Matyakhina L; Bei T; Stergiopoulos S; Papageorgiou T; Bourdeau I; Kirschner LS; Vincent-Dejean C; Perlemoine K; Gicquel C; Bertagna X; Stratakis CA
    Cancer Res; 2003 Sep; 63(17):5308-19. PubMed ID: 14500362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of the Carney complex gene 1 (protein kinase A regulatory subunit 1A) inhibits SMAD3 expression and TGF beta-stimulated apoptosis in adrenocortical cells.
    Ragazzon B; Cazabat L; Rizk-Rabin M; Assie G; Groussin L; Fierrard H; Perlemoine K; Martinez A; Bertherat J
    Cancer Res; 2009 Sep; 69(18):7278-84. PubMed ID: 19738044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of PKA regulatory subunit 1A protein is related to proliferation of human melanoma cells.
    Mantovani G; Bondioni S; Lania AG; Rodolfo M; Peverelli E; Polentarutti N; Veliz Rodriguez T; Ferrero S; Bosari S; Beck-Peccoz P; Spada A
    Oncogene; 2008 Mar; 27(13):1834-43. PubMed ID: 17906691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cAMP signaling in cortisol-producing adrenal adenoma.
    Calebiro D; Di Dalmazi G; Bathon K; Ronchi CL; Beuschlein F
    Eur J Endocrinol; 2015 Oct; 173(4):M99-106. PubMed ID: 26139209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase A alterations in adrenocortical tumors.
    Espiard S; Ragazzon B; Bertherat J
    Horm Metab Res; 2014 Nov; 46(12):869-75. PubMed ID: 25105543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational analysis of PRKAR1A and Gs(alpha) in sporadic adrenocortical tumors.
    Libé R; Mantovani G; Bondioni S; Lania AG; Pedroni C; Beck-Peccoz P; Spada A
    Exp Clin Endocrinol Diabetes; 2005 May; 113(5):248-51. PubMed ID: 15926108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRKAR1A mutations in primary pigmented nodular adrenocortical disease.
    Cazabat L; Ragazzon B; Groussin L; Bertherat J
    Pituitary; 2006; 9(3):211-9. PubMed ID: 17036196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroidogenic Acute Regulatory Protein Overexpression Correlates with Protein Kinase A Activation in Adrenocortical Adenoma.
    Zhou W; Wu L; Xie J; Su T; Jiang L; Jiang Y; Cao Y; Liu J; Ning G; Wang W
    PLoS One; 2016; 11(9):e0162606. PubMed ID: 27606678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary pigmented nodular adrenocortical disease reveals insulin-like growth factor binding protein-2 regulation by protein kinase A.
    Shi Z; Henwood MJ; Bannerman P; Batista D; Horvath A; Guttenberg M; Stratakis CA; Grimberg A
    Growth Horm IGF Res; 2007 Apr; 17(2):113-21. PubMed ID: 17280861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cyclic adenosine 3',5'-monophosphate/protein kinase a pathway on markers of cell proliferation in nonfunctioning pituitary adenomas.
    Mantovani G; Bondioni S; Ferrero S; Gamba B; Ferrante E; Peverelli E; Corbetta S; Locatelli M; Rampini P; Beck-Peccoz P; Spada A; Lania AG
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6721-4. PubMed ID: 16204369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 8-Cl-adenosine inhibits proliferation and causes apoptosis in B-lymphocytes via protein kinase A-dependent and independent effects: implications for treatment of Carney complex-associated tumors.
    Robinson-White AJ; Bossis I; Hsiao HP; Nesterova M; Leitner WW; Stratakis CA
    J Clin Endocrinol Metab; 2009 Oct; 94(10):4061-9. PubMed ID: 19773399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activating mutations of GNAS in canine cortisol-secreting adrenocortical tumors.
    Kool MM; Galac S; Spandauw CG; Kooistra HS; Mol JA
    J Vet Intern Med; 2013; 27(6):1486-92. PubMed ID: 24112376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase A subunit expression is altered in Bloom syndrome fibroblasts and the BLM protein is increased in adrenocortical hyperplasias: inverse findings for BLM and PRKAR1A.
    Heyerdahl SL; Boikos S; Horvath A; Giatzakis C; Bossis I; Stratakis CA
    Horm Metab Res; 2008 Jun; 40(6):391-7. PubMed ID: 18401830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compensatory stabilization of RIIbeta protein, cell cycle deregulation, and growth arrest in colon and prostate carcinoma cells by antisense-directed down-regulation of protein kinase A RIalpha protein.
    Nesterova M; Noguchi K; Park YG; Lee YN; Cho-Chung YS
    Clin Cancer Res; 2000 Sep; 6(9):3434-41. PubMed ID: 10999726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease.
    Groussin L; Jullian E; Perlemoine K; Louvel A; Leheup B; Luton JP; Bertagna X; Bertherat J
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4324-9. PubMed ID: 12213893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.